arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Privia Health Group, Inc.

PRVA

$22.45 ▲ +0.45 (+2.02%) at close

7 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

Privia Health Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.7B

Dividend Yield —

Revenue Growth 22.3% ↗

Op. Margin 1.6% ↗

ROIC 3.1% ↗

FCF / Share $1.34 ↗

Trailing P/E 118.2x

Price / Book 3.8x

FCF Yield 6.0%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.12B

↑ +22.3% —

Net Income Profit after all expenses

$22.92M

↑ +59.3% —

Operating Margin Operating profit as % of sales

1.6%

↑ +64.9% 32th

FCF / Share Free cash flow per share

$1.34

↑ +46.1% —

Health Breakdown

Profitability ↑

Returns

Financial Health

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	22.3% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+178%)	4.7% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-41%)	22.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+177%)	40.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+405%)	18.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+128%)	3.9% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-51%)	—
EPS Growth YoY (%)	58.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-40.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	95.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	266.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	59.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-37.7% Weak Weak Year-over-year change in net income	N/M	95.4% Excellent Excellent Year-over-year change in net income	N/M	279.0% Excellent Excellent Year-over-year change in net income	—
FCF Growth YoY (%)	46.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	32.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	62.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-19.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	31.9% Excellent Excellent Year-over-year change in free cash flow	106.5% Excellent Excellent Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	16.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	21.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	26.6% Excellent Excellent Compound annual revenue growth over 3 years	19.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	21.0% Excellent Excellent Compound annual revenue growth over 5 years	17.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	-15.4% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	1.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-89%)	1.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-93%)	1.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-92%)	-1.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-109%)	-22.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-250%)	3.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	2.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-86%)
Effective Tax Rate (%) (%)	32.3% Weak → Weak Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	38.8% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	27.5% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	35.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-31.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	1.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-91%)	0.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-93%)	1.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-88%)	-0.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-105%)	-19.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-262%)	3.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-68%)	1.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-91%)
FCF Margin (%) (%)	7.7% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.3% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	3.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	5.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	2.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	7.13x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	7.60x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	3.50x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-5.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good Good Free cash flow relative to reported net income Optimal: > 1x	2.26x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	3.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	1.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	2.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	22.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	1.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	2.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	7.7% Fair Fair Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	3.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	2.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	4.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-73%)	-1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-44.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-394%)	21.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+42%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	136.39x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	59.59x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	516.23x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-38.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-197.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	13.36x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	4.02x Fair Fair Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-479.69M	$-491.15M	$-389.51M	$-347.99M	$-320.58M	$-84.63M	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$17.38	$14.54	$14.20	$12.26	$9.39	$8.52	$8.20
Basic EPS, GAAP (USD)	$0.19	$0.12	$0.20	$-0.08	$-1.83	$0.33	$0.09
Free Cash Flow per Share (USD)	$1.34	$0.92	$0.69	$0.43	$0.53	$0.40	$0.19
Book Value per Share (USD)	$5.96	$5.28	$4.75	$4.35	$3.96	$1.53	—
Tangible Book Value per Share (USD)	$4.27	$4.10	$3.58	$3.24	$2.77	$0.29	—
Basic Weighted Avg Shares (shares)	122.18M	119.40M	116.73M	110.70M	102.95M	95.95M	95.93M

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$342.48M	$385.68M	$313.85M	$287.69M	$256.21M	$43.15M	—
Total Equity (USD)	$737.22M	$635.18M	$561.44M	$499.09M	$426.87M	$146.75M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$2.12B	$1.74B	$1.66B	$1.36B	$966.22M	$817.08M	$786.36M
Depreciation Expense (USD)	$9.91M	$7.27M	$6.53M	$4.57M	$2.46M	$1.84M	$1.43M
Net Income, GAAP (USD)	$22.92M	$14.38M	$23.08M	$-8.59M	$-188.23M	$31.24M	$8.24M
Operating Cash Flow (USD)	$163.40M	$109.28M	$80.78M	$47.20M	$55.06M	$38.89M	$24.36M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters

Privia Health Group, Inc.

Analytical Summary

7-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare PRVA with peers